A double blind, randomized, placebo-controlled trial on the use of recombinant human granulocyte-macrophage colony stimulating factor (Rh-GM-CSF) for the prevention and control of sepsis among low birth weight infants at the UP-PGH medical center

A double blind, randomized, placebo-controlled trial on the use of recombinant human granulocyte-macrophage colony stimulating factor (Rh-GM-CSF) for the prevention and control of sepsis among low birth weight infants at the UP-PGH medical center

Objectives: To determine if rh-GMCSF can significantly decrease the overall mortality rate and morbidity of low birth weight infants. Design: Experimental study. Double blind randomized placebo controlled design. Setting: Tertiary care university neonatal intensive care unit. Patients/Participants:...

Full description

Bibliographic Details
Main Author: Mantaring, Jacinto Blas V.
Format: Thesis
Subjects:
Septicemia.
Sepsis.